KYTRIL Side Effects

6932818-5 | Constipation, Hiccups, Liver Abscess
on Aug 09, 2010 Male patient from JAPAN , weighting 141.1 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), hiccups, liver abscess. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), XELODA (View Xeloda Review and Xeloda Label ), ELPLAT (View Elplat Review and Elplat Label ), UFT (Note:200 Mg, 200mg, 100 Mg.) (View Uft Review and Uft Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), DEXART (View Dexart Review and Dexart Label ), SHITEI (Dose Form : Peroral Agent) (View Shitei Review and Shitei Label ), HERBALAX (Reported:herbal Medicine Form:granulated Powder.) (View Herbalax Review and Herbalax Label ). Patient was hospitalized.

6879864-8 | Constipation, Hypertension, Large Intestine Perforation
Patient was taking Kytril (View Usage). Patient had the following side effects: constipation (What is constipation?), hypertension, large intestine perforation on Jul 13, 2010 from JAPAN Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with vomiting, rectal cancer metastatic and. Kytril dosage: . During the same period patient was treated with AVASTIN (Dose Form: Injection) (View Avastin Review and Avastin Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6756308-8 | Dizziness, Hyperhidrosis, Nausea
Adverse event was reported on May 31, 2010 by a Female patient taking Kytril (View Usage) (Dosage: ) . Location: AUSTRALIA , weighting 153.4 lb, After Kytril was administered, patient had the following side effects: dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?). During the same period patient was treated with METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), MORPHINE (View Morphine Review and Morphine Label ), DALTEPARIN SODIUM (Dose:5000 Int) (View Dalteparin Sodium Review and Dalteparin Sodium Label ), OXYCODONE HYDROCHLORIDE (View Oxycodone Hydrochloride Review and Oxycodone Hydrochloride Label ). Patient was hospitalized.

6746357-8 | Subileus
on May 20, 2010 Female patient from ITALY , weighting 149.9 lb, was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: subileus. Kytril dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATINE (View Oxaliplatine Review and Oxaliplatine Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), BLOPRESID (View Blopresid Review and Blopresid Label ), NAVOBAN (Total Daily Dose: 5mg/5ml) (View Navoban Review and Navoban Label ), MEPRAL (View Mepral Review and Mepral Label ), FLEBOCORTID (View Flebocortid Review and Flebocortid Label ), TRIMETON (Total Daily Dose; 1ml/10mg) (View Trimeton Review and Trimeton Label ). Patient was hospitalized.


6739588-4 | Intestinal Obstruction
on May 20, 2010 Female patient from ITALY , weighting 149.9 lb, was treated with Kytril (View Usage). Patient had the following side effects: intestinal obstruction. Kytril dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATINE (View Oxaliplatine Review and Oxaliplatine Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), BLOPRESID (View Blopresid Review and Blopresid Label ), NAVOBAN (Total Daily Dose: 5mg/5ml) (View Navoban Review and Navoban Label ), MEPRAL (View Mepral Review and Mepral Label ), FLEBOCORTID (View Flebocortid Review and Flebocortid Label ), TRIMETON (Total Daily Dose; 1ml/10mg) (View Trimeton Review and Trimeton Label ). Patient was hospitalized.

6715623-4 | Serotonin Syndrome
Patient was taking Kytril (View Usage). After Kytril was administered, patient had the following side effects: serotonin syndrome on Apr 26, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 233.7 lb, was diagnosed with nausea (What is nausea?), depressive symptom, parathyroid gland operation, surgery (What is surgery?) and. Kytril dosage: . During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), METHYLENE BLUE (View Methylene Blue Review and Methylene Blue Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ).

6599663-4 | Facial Bones Fracture
Adverse event was reported on Feb 19, 2010 by a Male patient taking Kytril (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: ECUADOR , weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: facial bones fracture. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (Dose: 20mg/ml.) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6576788-0 | Pruritus, Rash Maculo-papular, Thrombocytopenia
on Feb 05, 2010 Male patient from FRANCE , 54 years of age, was treated with Kytril (View Usage). Patient had the following side effects: pruritus, rash maculo-papular, thrombocytopenia. Kytril dosage: . During the same period patient was treated with GEMZAR (Second Cycle Was Postponed For A Little While) (View Gemzar Review and Gemzar Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6506641-X | Oedema, Somnolence
on Dec 15, 2009 Female patient from JAPAN , 66 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: oedema, somnolence. Kytril dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), NARCOTIC NOS (View Narcotic Nos Review and Narcotic Nos Label ).

6439002-2 | Bradycardia, Circulatory Collapse, Dizziness, Hypotension, Presyncope
Patient was taking Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, circulatory collapse, dizziness (What is dizziness?), hypotension, presyncope on Nov 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with antiemetic supportive care, non-hodgkin's lymphoma and. Kytril dosage: Indication Reported As Antiemetic Prior To Chemo. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PIRITON (Indication Reported As Premed) (View Piriton Review and Piriton Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), HYDROCORTISONE (Indication Reported As Pre Med) (View Hydrocortisone Review and Hydrocortisone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6427950-9 | Convulsion
Adverse event was reported on Oct 26, 2009 by a Male patient taking Kytril (View Usage) (Dosage: Route: Intravenous (not Otherwise Specified)) was diagnosed with prophylaxis of nausea and vomiting and. Location: JAPAN , 70 years of age, Patient had the following side effects: convulsion. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ).

6419181-3 | Grand Mal Convulsion
on Oct 26, 2009 Female patient from SOUTH AFRICA , weighting 136.7 lb, was diagnosed with anaesthesia and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: grand mal convulsion. Kytril dosage: . During the same period patient was treated with SUPRANE (View Suprane Review and Suprane Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), MORPHINE (View Morphine Review and Morphine Label ), ULTIVA (View Ultiva Review and Ultiva Label ), DECADRON (View Decadron Review and Decadron Label ), TRACRIUM (View Tracrium Review and Tracrium Label ).

6392005-9 | Arrhythmia, Cardiac Arrest, Cerebral Haematoma, Dystonia, Hypoxic Encephalopathy, Myocardial Infarction, No Therapeutic Response, Rib Fracture, Ventricular Fibrillation
on Sep 29, 2009 Female patient from AUSTRALIA , weighting 174.2 lb, was diagnosed with nausea (What is nausea?), colon cancer and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), cardiac arrest (What is cardiac arrest?), cerebral haematoma, dystonia (What is dystonia?), hypoxic encephalopathy, myocardial infarction, no therapeutic response, rib fracture, ventricular fibrillation. Kytril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

6389474-7 | Hepatitis
Patient was taking Kytril (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?) on Sep 25, 2009 from JAPAN Additional patient health information: Female patient , weighting 135.4 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), GASTER D (View Gaster D Review and Gaster D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), DEXART (Route: Injectable (not Otherwise Specified)) (View Dexart Review and Dexart Label ), NAUZELIN (Form: Oral Formulation (not Otherwise Specified)) (View Nauzelin Review and Nauzelin Label ).

6360853-7 | Pneumonia
Adverse event was reported on Sep 10, 2009 by a Male patient taking Kytril (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: JAPAN , weighting 160.9 lb, After Kytril was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), OMEPRAL (View Omepral Review and Omepral Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6355079-7 | Deep Vein Thrombosis, Metastases To Liver
on Sep 04, 2009 Female patient from UNITED KINGDOM , weighting 154.3 lb, was diagnosed with prophylaxis, deep vein thrombosis (What is deep vein thrombosis?), colon cancer and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), metastases to liver. Kytril dosage: . During the same period patient was treated with CAPECITABINE (Cummulative Dose 196 Grams Unk) (View Capecitabine Review and Capecitabine Label ), BEVACIZUMAB (Cummulative Dose 1050 Mg Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Cummulative Dose 880 Mg Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6347212-8 | Renal Impairment
on Aug 26, 2009 Male patient from JAPAN , weighting 145.5 lb, was diagnosed with rectal cancer metastatic and was treated with Kytril (View Usage). Patient had the following side effects: renal impairment. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), DEXART (View Dexart Review and Dexart Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIOVAN (View Diovan Review and Diovan Label ).

6336921-2 | Dystonia, Myocardial Infarction
Patient was taking Kytril (View Usage). After Kytril was administered, patient had the following side effects: dystonia (What is dystonia?), myocardial infarction on Aug 25, 2009 from AUSTRALIA Additional patient health information: Female patient , 62 years of age, . Kytril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6314424-9 | Blood Pressure Decreased, Bradycardia, Circulatory Collapse
Adverse event was reported on Aug 10, 2009 by a Male patient taking Kytril (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED KINGDOM , 50 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bradycardia, circulatory collapse. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PIRITON (View Piriton Review and Piriton Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6307125-4 | Diarrhoea, Hepatic Failure, Lactic Acidosis, Renal Failure Acute
on Aug 07, 2009 Male patient from SPAIN , 70 years of age, was diagnosed with rectal cancer and was treated with Kytril (View Usage). Patient had the following side effects: diarrhoea, hepatic failure, lactic acidosis, renal failure acute. Kytril dosage: Unk. During the same period patient was treated with CAPECITABINE (3.4 G) (View Capecitabine Review and Capecitabine Label ), OXALIPLATIN (249 Mg) (View Oxaliplatin Review and Oxaliplatin Label ).

6260107-3 | Colitis Ischaemic
on Jun 30, 2009 Female patient from JAPAN , weighting 129.6 lb, was diagnosed with colon cancer, prophylaxis of nausea and vomiting, constipation (What is constipation?) and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: colitis ischaemic. Kytril dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (Route: Intravenous Bolus) (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), DECADRON (View Decadron Review and Decadron Label ), PURSENNID (Note: Taken As Needed) (View Pursennid Review and Pursennid Label ), LOXONIN (Note: Taken As Needed) (View Loxonin Review and Loxonin Label ). Patient was hospitalized.

6259340-6 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: reversible posterior leukoencephalopathy syndrome on Jun 30, 2009 from AUSTRALIA Additional patient health information: Female patient , weighting 130.7 lb, was diagnosed with colorectal cancer metastatic and. Kytril dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AFLIBERCEPT (View Aflibercept Review and Aflibercept Label ). Patient was hospitalized.

6259335-2 | Cerebral Haematoma, Cough, Dyspnoea, Face Oedema, Hypertension, Oedema Peripheral, Subarachnoid Haemorrhage
Adverse event was reported on Jun 30, 2009 by a Male patient taking Kytril (View Usage) (Dosage: 1 Mg) was diagnosed with vomiting, colorectal cancer metastatic and. Location: SPAIN , 50 years of age, Patient had the following side effects: cerebral haematoma, cough, dyspnoea, face oedema, hypertension, oedema peripheral, subarachnoid haemorrhage. During the same period patient was treated with CALCIUM FOLINATE (300 Mg) (View Calcium Folinate Review and Calcium Folinate Label ), AVASTIN (262 Mg) (View Avastin Review and Avastin Label ), ELOXATIN (125 Mg) (View Eloxatin Review and Eloxatin Label ), FLUOROURACILO (1.5 G) (View Fluorouracilo Review and Fluorouracilo Label ), FORTECORTIN (16 Mg) (View Fortecortin Review and Fortecortin Label ). Patient was hospitalized.

6251784-1 | Bronchopneumonia, Deep Vein Thrombosis, Metastases To Liver
on Jun 22, 2009 Female patient from ROMANIA , weighting 154.3 lb, was diagnosed with prophylaxis, deep vein thrombosis (What is deep vein thrombosis?), colon cancer and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: bronchopneumonia, deep vein thrombosis (What is deep vein thrombosis?), metastases to liver. Kytril dosage: . During the same period patient was treated with CAPECITABINE (Cummulative Dose 196 Grams Unk) (View Capecitabine Review and Capecitabine Label ), BEVACIZUMAB (Cummulative Dose 1050 Mg Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Cummulative Dose 880 Mg Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6248483-9 | Hepatitis
on Jun 17, 2009 Female patient from JAPAN , weighting 135.4 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), GASTER D (View Gaster D Review and Gaster D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), DEXART (Route: Injectable (not Otherwise Specified)) (View Dexart Review and Dexart Label ), NAUZELIN (Form: Oral Formulation (not Otherwise Specified)) (View Nauzelin Review and Nauzelin Label ).

6245728-6 | Acute Hepatic Failure, Deep Vein Thrombosis
Patient was taking Kytril (View Usage). Patient had the following side effects: acute hepatic failure, deep vein thrombosis (What is deep vein thrombosis?) on Jun 22, 2009 from ROMANIA Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with prophylaxis, deep vein thrombosis (What is deep vein thrombosis?), colon cancer and. Kytril dosage: . During the same period patient was treated with CAPECITABINE (Cummulative Dose 196 Grams Unk) (View Capecitabine Review and Capecitabine Label ), BEVACIZUMAB (Cummulative Dose 1050 Mg Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Cummulative Dose 880 Mg Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6200347-2 | Pelvic Abscess
Adverse event was reported on May 14, 2009 by a Female patient taking Kytril (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting, gastric cancer, pain (What is pain?) and. Location: UNITED STATES , weighting 134.3 lb, After Kytril was administered, patient had the following side effects: pelvic abscess. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DECADRON (View Decadron Review and Decadron Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), VICODIN (5/500 Mg) (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

6197653-7 | Vomiting
on Jan 30, 2009 Male patient from UNITED STATES , child 11 years of age, was diagnosed with mitochondrial cytopathy and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: vomiting. Kytril dosage: . Patient was hospitalized.

6185309-6 | Hypertransaminasaemia, Mucosal Inflammation
on Apr 27, 2009 Male patient from SPAIN , 21 years of age, was diagnosed with bone sarcoma and was treated with Kytril (View Usage). Patient had the following side effects: hypertransaminasaemia, mucosal inflammation. Kytril dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6182476-5 | Angina Pectoris, Nausea
Patient was taking Kytril (View Usage). After Kytril was administered, patient had the following side effects: angina pectoris, nausea (What is nausea?) on Apr 27, 2009 from FINLAND Additional patient health information: Female patient , 49 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Kytril dosage: Reported As According To Need.. During the same period patient was treated with XELODA (Frequency : 5+ 5/day) (View Xeloda Review and Xeloda Label ), PRIMPERAN (Reported As According To Need.) (View Primperan Review and Primperan Label ).

6182446-7 | Abdominal Pain Upper, Dysphagia, Fall, Hyponatraemia, Ischaemic Stroke, Malaise
Adverse event was reported on Apr 24, 2009 by a Male patient taking Kytril (View Usage) (Dosage: Dose Reported As 3 (nos), Varying With Cycles) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: FRANCE , weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dysphagia, fall (What is fall?), hyponatraemia, ischaemic stroke, malaise. During the same period patient was treated with AVASTIN (Frequency: Per Cycle) (View Avastin Review and Avastin Label ), SOLU MEDROL (Varying With Cycles) (View Solu-medrol Review and Solu-medrol Label ), CAMPTOSAR (Varying) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ELVORINE (Dose Varying With Cycles) (View Elvorine Review and Elvorine Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6172863-3 | Blood Pressure Increased, Convulsion
on Apr 17, 2009 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and was treated with Kytril (View Usage). Patient had the following side effects: blood pressure increased, convulsion. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (Route: Intravenous Bolus) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6170000-2 | Ill-defined Disorder
on Apr 10, 2009 Female patient from ITALY , weighting 149.9 lb, was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: ill-defined disorder. Kytril dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), BLOPRESID (View Blopresid Review and Blopresid Label ), NAVOBAN (View Navoban Review and Navoban Label ), MEPRAL (View Mepral Review and Mepral Label ), FLEBOCORTID (View Flebocortid Review and Flebocortid Label ), TRIMETON (View Trimeton Review and Trimeton Label ). Patient was hospitalized.

6168019-0 | Alopecia, Anorexia, Constipation, Diarrhoea, Malaise, Nausea, Neuropathy Peripheral, Neutrophil Count Decreased, Tonsillitis
Patient was taking Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, anorexia, constipation (What is constipation?), diarrhoea, malaise, nausea (What is nausea?), neuropathy peripheral, neutrophil count decreased, tonsillitis on Apr 16, 2009 from JAPAN Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with prophylaxis of nausea and vomiting, rectal cancer metastatic, gastrointestinal disorder, neuropathy peripheral and. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (Route: Intravenous Bolus.) (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), LAC B (View Lac-b Review and Lac-b Label ), SHAKUYAKU KANZO TO (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6152685-X | Abdominal Pain Upper, Dysphagia, Fall, Hyponatraemia, Ischaemic Stroke, Malaise
Adverse event was reported on Apr 03, 2009 by a Male patient taking Kytril (View Usage) (Dosage: Dose Reported As 3 (nos)) . Location: FRANCE , weighting 127.9 lb, Patient had the following side effects: abdominal pain upper, dysphagia, fall (What is fall?), hyponatraemia, ischaemic stroke, malaise. During the same period patient was treated with AVASTIN (Dosage: 315 (nos)) (View Avastin Review and Avastin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), CAMPTOSAR (Dose Reported As 303) (View Camptosar Review and Camptosar Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6148002-1 | Peritonitis
on Mar 30, 2009 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with prophylaxis of nausea and vomiting, rectal cancer metastatic, abdominal pain upper, abdominal discomfort and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: peritonitis. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), DECADRON (Route: Intravenous (nos)) (View Decadron Review and Decadron Label ), HYPEN (View Hypen Review and Hypen Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), GASTROM (View Gastrom Review and Gastrom Label ). Patient was hospitalized.

6133547-0 | Rhabdomyolysis
on Mar 03, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Kytril dosage: . During the same period patient was treated with LIVALO (View Livalo Review and Livalo Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6124105-2 | Neuropathy Peripheral
Patient was taking Kytril (View Usage). Patient had the following side effects: neuropathy peripheral on Mar 09, 2009 from JAPAN Additional patient health information: Male patient , weighting 121.3 lb, was diagnosed with colon cancer and. Kytril dosage: . During the same period patient was treated with SEROTONE (View Serotone Review and Serotone Label ), DEXAMETHASONE PALMITATE (View Dexamethasone Palmitate Review and Dexamethasone Palmitate Label ), FLUOROURACIL (620mg/body (400mg/m2) In Bolus Then 930mg/body (600mg/m2) As Continuous Infusion) (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), ELPLAT (View Elplat Review and Elplat Label ).

6120846-1 | Alopecia, Anorexia, Constipation, Diarrhoea, Malaise, Nausea, Neuropathy Peripheral, Neutrophil Count Decreased, Tonsillitis
Adverse event was reported on Mar 09, 2009 by a Male patient taking Kytril (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting, rectal cancer metastatic, gastrointestinal disorder, neuropathy peripheral and. Location: JAPAN , weighting 180.8 lb, After Kytril was administered, patient had the following side effects: alopecia, anorexia, constipation (What is constipation?), diarrhoea, malaise, nausea (What is nausea?), neuropathy peripheral, neutrophil count decreased, tonsillitis. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (Route: Intravenous Bolus.) (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), LAC B (View Lac-b Review and Lac-b Label ), SHAKUYAKU KANZO TO (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6110282-6 | Laryngospasm
on Feb 26, 2009 Male patient from FINLAND , weighting 149.9 lb, was diagnosed with rectal cancer and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: laryngospasm. Kytril dosage: Form: Infusion. During the same period patient was treated with AVASTIN (Form: Infusion) (View Avastin Review and Avastin Label ), OXALIPLATIN (Form: Infusion) (View Oxaliplatin Review and Oxaliplatin Label ), ORADEXON TAB (Form: Infusion) (View Oradexon Tab Review and Oradexon Tab Label ), LISIPRIL (View Lisipril Review and Lisipril Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), SOMAC (View Somac Review and Somac Label ). Patient was hospitalized.

6073666-0 | Pulmonary Artery Thrombosis
on Feb 03, 2009 Male patient from JAPAN , 73 years of age, weighting 132.9 lb, was diagnosed with rectal cancer recurrent and was treated with Kytril (View Usage). Patient had the following side effects: pulmonary artery thrombosis. Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), ELPLAT (View Elplat Review and Elplat Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), DEXART (View Dexart Review and Dexart Label ).

6044508-4 | Convulsion
Patient was taking Kytril (View Usage). After Kytril was administered, patient had the following side effects: convulsion on Jan 09, 2009 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Kytril dosage: Route: Intravenous (not Otherwise Specified). During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ).

6006590-X | Convulsion, Status Epilepticus
Adverse event was reported on Dec 08, 2008 by a Female patient taking Kytril (View Usage) (Dosage: ) was diagnosed with hypotension and. Location: SOUTH AFRICA , 38 years of age, Patient experienced the following unwanted or unexpected effects: convulsion, status epilepticus. During the same period patient was treated with EFFORTIL (View Effortil Review and Effortil Label ). Patient was hospitalized.

6003953-3 | Hepatitis
on Dec 05, 2008 Female patient from JAPAN , weighting 135.4 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer metastatic and was treated with Kytril (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Kytril dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE (View Levofolinate Review and Levofolinate Label ), GASTER D (View Gaster D Review and Gaster D Label ), MAGMITT (View Magmitt Review and Magmitt Label ), DEXART (Route: Injectable (not Otherwise Specified)) (View Dexart Review and Dexart Label ), NAUZELIN (Form: Oral Formulation (not Otherwise Specified)) (View Nauzelin Review and Nauzelin Label ).

5976039-1 | Cardiac Disorder, Myocardial Infarction
on Nov 25, 2008 Female patient from SOUTH AFRICA , weighting 116.8 lb, was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: cardiac disorder, myocardial infarction. Kytril dosage: Indication: Pre-op N+v. During the same period patient was treated with MAXOLON (View Maxolon Review and Maxolon Label ). Patient was hospitalized.

5971196-5 | Hot Flush, Muscle Twitching, Swollen Tongue
Patient was taking Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: hot flush, muscle twitching, swollen tongue on Nov 17, 2008 from AUSTRALIA Additional patient health information: Female patient , 66 years of age, was diagnosed with antiemetic supportive care and. Kytril dosage: . During the same period patient was treated with EMEND (View Emend Review and Emend Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5879779-8 | Hot Flush, Muscle Twitching, Swollen Tongue
Adverse event was reported on Sep 02, 2008 by a Female patient taking Kytril (View Usage) (Dosage: ) was diagnosed with antiemetic supportive care and. Location: AUSTRALIA , 66 years of age, Patient had the following side effects: hot flush, muscle twitching, swollen tongue. During the same period patient was treated with APREPITANT (View Aprepitant Review and Aprepitant Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5864213-4 | Anaphylactic Shock
on Aug 20, 2008 Male patient from JAPAN , weighting 55.12 lb, was diagnosed with prophylaxis of nausea and vomiting, non-hodgkin's lymphoma and was treated with Kytril (View Usage). After Kytril was administered, patient had the following side effects: anaphylactic shock. Kytril dosage: Route: Intravenous (not Otherwise Specified). During the same period patient was treated with ONCOVIN (Route: Intravenous (not Otherwise Specified)) (View Oncovin Review and Oncovin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), PREDONINE (View Predonine Review and Predonine Label ).

5852958-1 | Peritonitis
on Aug 13, 2008 Female patient from JAPAN , weighting 158.7 lb, was diagnosed with colon cancer, infection (What is infection?), gastritis, pyrexia and was treated with Kytril (View Usage). Patient experienced the following unwanted or unexpected effects: peritonitis. Kytril dosage: . During the same period patient was treated with FLUOROURACIL (700 Mg/body=404.6 Mg/m2 In Bolus Then 4050 Mg/body=2341 Mg/m2 As Continuous Infusion) (View Fluorouracil Review and Fluorouracil Label ), ELPLAT (View Elplat Review and Elplat Label ), DECADRON SRC (View Decadron Src Review and Decadron Src Label ), BROACT (View Broact Review and Broact Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ), FLOMOX (View Flomox Review and Flomox Label ).

5843500-X | Anaphylactic Shock
Patient was taking Kytril (View Usage). Patient had the following side effects: anaphylactic shock on Aug 01, 2008 from JAPAN Additional patient health information: Male patient , weighting 55.12 lb, was diagnosed with prophylaxis of nausea and vomiting and. Kytril dosage: Route: Intravenous(not Other Wise Specified). During the same period patient was treated with ONCOVIN (Route: Injectable (not Otherwise Specified)) (View Oncovin Review and Oncovin Label ), ENDOXAN (Route: Intravenous( Not Other Wise Specified).) (View Endoxan Review and Endoxan Label ), DAUNOMYCIN (Route: Intravenous (not Other Wise Specified).) (View Daunomycin Review and Daunomycin Label ), PREDONINE (View Predonine Review and Predonine Label ).